Stem Cell and Molecular Biology Laboratory, Department of Biotechnology, Indian Institute of Technology Madras, Chennai 600036 TN, India.
Cell Tissue Res. 2012 Feb;347(2):383-95. doi: 10.1007/s00441-012-1328-5. Epub 2012 Feb 7.
Umbilical cord blood serum (UCBS) is a promising replacement for animal sera for the culture of human mesenchymal stem cells (hMSC), the unique serum composition of UCBS appearing to have variable effects on their proliferation and differentiation. Conditioning UCBS with methods such as charcoal stripping assists specific processes such as adipogenesis and osteogenesis in hMSCs. The charcoal stripping of serum removes lipophilic materials such as oestrogens, which are known inhibitors of adipogenesis. hMSC cultures supplemented with charcoal-stripped UCBS (CS-UCBS) show enhanced adipogenesis in adipogenic induction medium (AIM) containing indomethacin, 3-isobutyl-1-methylxanthine and dexamethasone. To obtain efficient adipogenesis without CS-UCBS, we have developed a modified protocol in which cells cultured separately with UCBS and CS-UCBS are constantly treated with minimal doses of insulin (1.1 μg/ml) for 10 days prior to the addition of AIM. hMSC cultures differentiated by using the modified protocol show improved adipogenesis under fetal bovine serum (FBS), UCBS and CS-UCBS conditions, with levels of adipogenesis being highest in UCBS, thereby eliminating the need for charcoal stripping. Furthermore, in each of the three sera, the insulin-pre-treated hMSCs accumulate lipid droplets faster and exhibit improved adipogenesis overall when compared with normal AIM-induced adipogenesis. We have also compared the levels of osteogenesis in hMSCs by using an induction medium devoid of dexamethasone. Maximum calcium deposition has been observed in hMSCs cultured with UCBS, as compared with those cultured with FBS or CS-UCBS. Our newly developed methods with a humanized serum supplement thus enhance the differentiation of cultured hMSCs.
脐带血清(UCBS)是一种有前途的动物血清替代品,可用于培养人骨髓间充质干细胞(hMSC),UCBS 的独特血清成分似乎对其增殖和分化有不同的影响。通过用活性炭处理等方法对 UCBS 进行预处理,可以促进 hMSC 中的特定过程,如脂肪生成和骨生成。血清的活性炭处理去除了亲脂性物质,如雌激素,雌激素是脂肪生成的已知抑制剂。在含有消炎痛、3-异丁基-1-甲基黄嘌呤和地塞米松的脂肪生成诱导培养基(AIM)中,补充了活性炭处理的 UCBS(CS-UCBS)的 hMSC 培养物显示出增强的脂肪生成。为了在没有 CS-UCBS 的情况下获得有效的脂肪生成,我们开发了一种改良的方案,其中细胞分别在 UCBS 和 CS-UCBS 中培养,并在添加 AIM 之前连续用最小剂量的胰岛素(1.1μg/ml)处理 10 天。使用改良方案分化的 hMSC 培养物在胎牛血清(FBS)、UCBS 和 CS-UCBS 条件下显示出改善的脂肪生成,其中在 UCBS 中的脂肪生成水平最高,从而消除了对活性炭处理的需求。此外,在这三种血清中,与正常 AIM 诱导的脂肪生成相比,用胰岛素预处理的 hMSCs 在每种血清中更快地积累脂滴,并表现出整体改善的脂肪生成。我们还比较了使用不含地塞米松的诱导培养基中 hMSC 的成骨水平。与在 FBS 或 CS-UCBS 中培养的 hMSC 相比,在 UCBS 中培养的 hMSC 观察到最大的钙沉积。我们新开发的方法与人性化的血清补充相结合,从而增强了培养的 hMSC 的分化。